Marín F - Search Results

1

[Atrial fibrillation in patients with COVID-19. Usefulness of the CHA₂DS₂-VASc score: an analysis of the international HOPE COVID-19 registry].

Uribarri A, Núñez-Gil IJ, Aparisi Á, Arroyo-Espliguero R, Maroun Eid C, Romero R, Becerra-Muñoz VM, Feltes G, Molina M, García-Aguado M, Cerrato E, Capel-Astrua T, Alfonso-Rodríguez E, Castro-Mejía AF, Raposeiras-Roubín S, Espejo C, Pérez-Solé N, Bardají A, Marín F, Fabregat-Andrés Ó, D'ascenzo F, Santoro F, Akin I, Estrada V, Fernández-Ortiz A, Macaya C; en representación de los investigadores HOPE COVID-19. Uribarri A, et al. Among authors: marin f. Rev Esp Cardiol. 2021 Jul;74(7):608-615. doi: 10.1016/j.recesp.2020.12.014. Epub 2021 Mar 2. Rev Esp Cardiol. 2021. PMID: 33678938 Free PMC article. Spanish.

2

[Prognostic value of serum levels of tumor necrosis factor-alpha in patients with heart failure].

Jordán AJ, Esteban A, García M, Monmeneu JV, Espinosa D, Reyes F, Luján J, Climent V, Marín F, García de Burgos F. Jordán AJ, et al. Among authors: marin f. Rev Esp Cardiol. 2003 Feb;56(2):160-7. doi: 10.1016/s0300-8932(03)76840-7. Rev Esp Cardiol. 2003. PMID: 12605761 Free article. Spanish.

3

[Effect of maximum dose of atorvastatin on inflammation, thrombogenesis and fibrinolysis in high-risk patients with ischemic heart disease].

Tello A, Marín F, Roldán V, García-Herola A, Lorenzo S, Climent VE, de Teresa L, Sogorb F. Tello A, et al. Among authors: marin f. Rev Esp Cardiol. 2005 Aug;58(8):934-40. Rev Esp Cardiol. 2005. PMID: 16053827 Free article. Spanish.

4

Gadolinium-enhanced cardiovascular magnetic resonance and exercise capacity in hypertrophic cardiomyopathy.

Romero-Puche A, Marín F, González-Carrillo J, García-Honrubia A, Climent V, Feliu E, Ruiz-Espejo F, Payá E, Gimeno-Blanes JR, de la Morena G, Valdés-Chavarri M. Romero-Puche A, et al. Among authors: marin f. Rev Esp Cardiol. 2008 Aug;61(8):853-60. Rev Esp Cardiol. 2008. PMID: 18684368 Free article. English, Spanish.

5

Does pacemaker implantation provide long-term benefits in severe obstructive hypertrophic cardiomyopathy?

Sandín M, Marín F, Cambronero F, Climent V, Caro C, Martínez JG, Honrubia AG, García Alberola A, de la Morena G, Valdés M, Sogorb F. Sandín M, et al. Among authors: marin f. Rev Esp Cardiol. 2009 Nov;62(11):1233-9. doi: 10.1016/s1885-5857(09)73350-x. Rev Esp Cardiol. 2009. PMID: 19889334 Free article.

6

Influence of CYP2C19 polymorphisms in platelet reactivity and prognosis in an unselected population of non ST elevation acute coronary syndrome.

Tello-Montoliu A, Jover E, Marín F, Bernal A, Lozano ML, Sánchez-Vega B, Pastor FJ, Hurtado JA, Valdés M, Vicente V, Rivera J. Tello-Montoliu A, et al. Among authors: marin f. Rev Esp Cardiol (Engl Ed). 2012 Mar;65(3):219-26. doi: 10.1016/j.recesp.2011.07.013. Epub 2011 Nov 23. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22116003 English, Spanish.

7

Predictive value of the CHA2DS2-VASc score in atrial fibrillation patients at high risk for stroke despite oral anticoagulation.

Jover E, Roldán V, Gallego P, Hernández-Romero D, Valdés M, Vicente V, Lip GY, Marín F. Jover E, et al. Among authors: marin f. Rev Esp Cardiol (Engl Ed). 2012 Jul;65(7):627-33. doi: 10.1016/j.recesp.2012.02.017. Epub 2012 May 18. Rev Esp Cardiol (Engl Ed). 2012. PMID: 22609214 English, Spanish.

8

[Should we add antiplatelet therapy to oral anticoagulation in patients with atrial fibrillation and vascular disease? Review of available evidence].

Andreu JM, Roldán V, García-Navarro M, Ruipérez JA, Valdés M, Marín F. Andreu JM, et al. Among authors: marin f. Arch Cardiol Mex. 2012 Jul-Sep;82(3):248-51. doi: 10.1016/j.acmx.2012.03.002. Epub 2012 Sep 14. Arch Cardiol Mex. 2012. PMID: 23021363 Spanish.

9

Use of antithrombotic therapy in patients with atrial fibrillation in primary care. Importance of INR control.

Leal-Hernández M, Marín F. Leal-Hernández M, et al. Among authors: marin f. Rev Esp Cardiol (Engl Ed). 2014 May;67(5):419. doi: 10.1016/j.rec.2014.02.003. Epub 2014 Apr 3. Rev Esp Cardiol (Engl Ed). 2014. PMID: 24774743 No abstract available.

10

Exercise eco-Doppler in hypertrophic cardiomyopathy patients. Determinant factors of exercise intolerance.

de la Morena G, Caro C, Saura D, Marín F, Gimeno JR, González J, Oliva MJ, García-Navarro M, López-Cuenca A, Espinosa MD, Valdés M. de la Morena G, et al. Among authors: marin f. Rev Esp Cardiol (Engl Ed). 2013 Feb;66(2):98-103. doi: 10.1016/j.rec.2012.06.011. Epub 2012 Sep 5. Rev Esp Cardiol (Engl Ed). 2013. PMID: 24775382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,162 results

Search Page

Filters